Oncologia
Prostate cancer: ESMO Consensus Conference Guidelines 2012
Scritto da Annals of Oncology - current issue   
Oncologia

The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological aspects. Before ... ...

... continua Aggiungi commento
 
Management of the axilla in early breast cancer patients in the genomic era
Scritto da Annals of Oncology - current issue   
Oncologia

Management of the axilla in early breast cancer (EBC) patients has dramatically evolved in recent years from more radical to increasingly conservative approaches. Classically, the EBC patients with a clinically positive axilla are offered axillar ... ...

... continua Aggiungi commento
 
Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer
Scritto da Annals of Oncology - current issue   
OncologiaBackground

Treatments of non-small-cell lung cancer (NSCLC)—particularly of the squamous subtype—are limited. In this article, we describe the immunomodulatory environment in NSCLC and the potential for therapeutic targe ... ...

... continua Aggiungi commento
 
Penile cancer: current therapy and future directions
Scritto da Annals of Oncology - current issue   
OncologiaBackground

Penile cancer (PC) is a rare cancer in western countries, but is more common in parts of the developing world. Due to its rarity and the consequent lack of randomized trials, current therapy is based on retrospective stud ... ...

... continua Aggiungi commento
 
Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and
Scritto da Annals of Oncology - current issue   
OncologiaBackground

Cancer patients frequently suffer from gastrointestinal complications. However, a comprehensive, practical and evidence-based guideline on this issue is not yet available.

Patients and methods

... ...

... continua Aggiungi commento
 
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98
Scritto da Annals of Oncology - current issue   
OncologiaBackground

In women with node-positive breast cancer, the Breast International Group (BIG) 02-98 tested the incorporation of docetaxel (Taxotere) into doxorubicin (Adriamycin)-based chemotherapy, and compared sequential and concurre ... ...

... continua Aggiungi commento
 
Adjuvant chemotherapy in elderly women with breast cancer (AChEW): an observational study identifying MDT perceptions and barriers to decision making
Scritto da Annals of Oncology - current issue   
OncologiaBackground

As few older women with breast cancer receive adjuvant chemotherapy, we examined the barriers and perceptions of 24 UK NHS multidisciplinary breast cancer teams to offering this treatment to women ≥70 years.

 ... ...
... continua Aggiungi commento
 
<< Inizio < Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >>

Pag 1 di 2861